524494:BOM
IPCA Laboratories Ltd
₹1,916.00
arrow_upward
+0.12%(+2.35) 1D
Oct 15, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524494...
Open
₹1,871.50
High
₹1,929.50
Low
₹1,871.50
Mkt. cap
484.07B
Avg. vol.
28.54K
Volume
8.36K
Dividend
0.31%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
37.11
52-wk high
₹2,039.30
52-wk low
₹1,252.95
EPS
₹51.63
Shares outstanding
126.35M
No. of employees
17K
Open
₹1,871.50
High
₹1,929.50
Low
₹1,871.50
Mkt. cap
484.07B
Avg. vol.
28.54K
Volume
8.36K
Dividend
0.31%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
37.11
52-wk high
₹2,039.30
52-wk low
₹1,252.95
EPS
₹51.63
Shares outstanding
126.35M
No. of employees
17K
News stories
From web sources and news partners
Investing.com
·
12 minutes ago
Dow jumps 556 pts while Nvidia keeps bleeding, our AI spotted the pivot weeks ago
Yahoo Finance
·
1 hour ago
The S&P 500 Went More Than 50 Trading Days Without a 1% Drop. That Streak Just Ended. What's Next?
The Spokesman-Review
·
1 hour ago
S&P 500 ends higher as traders shift from AI to healthcare
Traders Union
·
2 hours ago
S&P 500 may reach 10,000 by 2027, James E. Thorne predicts
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
About IPCA Laboratories Ltd